Breaking News

Alvotech Acquires Ivers-Lee Group

Expands its capacity for assembly and packaging for the pharmaceutical sector.

Alvotech, a global biotech company specializing in the development and manufacture of biosimilar medicines, has expanded its capacity for assembly and packaging with the acquisition of Ivers-Lee Group, a business with headquarters in Burgdorf, Switzerland specializing in providing assembly and packaging services for the pharmaceutical sector. While Ivers-Lee will remain a separate legal entity, its operations will be integrated into Alvotech’s Technical Operations division, supporting Alvotech’s plans for growth.

“Ivers-Lee has been an Alvotech preferred partner in assembly and packaging for several years. We know and trust each other very well, having worked closely together,” said Robert Wessman, founder, chairman and CEO of Alvotech. “As Alvotech prepares for the launch of three new biosimilars in 2025 and sales growth in global markets, the integration of Ivers-Lee into our Technical Operations, provides added flexibility and capacity to meet increased global demand for our biosimilars, maintaining the highest level of quality and service.”

In addition to the site in Burgdorf, Ivers-Lee also operates a strategic business unit in Lörrach, Germany.

Managing director Peter Schüpbach, grandson of Ivers-Lee’s founder, will remain managing director and member of the Board of Directors of Ivers-Lee Group. Furthermore, he will join the Technical Operations senior leadership team of Alvotech following the acquisition.

“Alvotech offers the Ivers-Lee Group financial strength and development opportunities in a growth market, that we as a founding family cannot offer. This change brings stability both for Ivers-Lee and its employees,” said Schüpbach.

Ivers-Lee’s site in Burgdorf is GMP licensed, and FDA approved. Among the capabilities that will be integrated with Alvotech’s operations are assembly and packaging of autoinjectors, pre-filled syringes and safety devices and packaging of vials. Ivers-Lee has an international customer base and will also continue servicing other existing clients and providing CMO services, including blister and stick-pack activities as well as clinical supplies and QP services, provided by the unit in Lörrach.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters